the present study was conducted to determine the characteristics related to response and survival in patients with stage iii and iv non-hodgkin 's lymphoma who were treated with combinations of cyclophosphamide , vincristine sulfate , and prednisone .
C0024305
non-hodgkin 's lymphoma
C0042680
vincristine sulfate